Focus on Infectious Disease
  • Saved

A drug costing less than $2 a day helps in the treatment of severely ill COVID-19 patients

A drug costing less than $2 a day helps in the treatment of severely ill COVID-19 patients

Source : https://medicalxpress.com/news/2021-08-drug-day-treatment-severely-ill.html

Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19 patients. This is the finding of a study by investigators at the Centro Nacional de...

  • Saved

New FDA Webform Makes It Easier For Device Makers To Report Shortages

New FDA Webform Makes It Easier For Device Makers To Report Shortages

Source : Medtech Insight

The US Food and Drug Administration on 3 August announced a new online webform to make it easier for makers of medical devices deemed critical to fighting the...

  • Saved

US FDA Touts Big Improvements In Product Review Process: Report

US FDA Touts Big Improvements In Product Review Process: Report

Source : Medtech Insight

In a new report the US Food and Drug Administration says it has met or exceeded all components of its 2018-2020 strategic priorities, including simplifying processes critical to product review.

The...

  • Saved

The Missing Link: COVID-19 Antibody Tests Need Buy-In From FDA

The Missing Link: COVID-19 Antibody Tests Need Buy-In From FDA

Source : IN VIVO

Along the patient’s journey of care for COVID-19, the use of antibody testing can play a critical role in the decision-making and management of the virus.

These tests not only...

  • Saved

The Indemnity Calculus For Covid-19 Vaccines, India’s Path Ahead

The Indemnity Calculus For Covid-19 Vaccines, India’s Path Ahead

Source : IN VIVO

Developing nations like India should consider consenting to pharma’s indemnity demand, albeit with sharp drafting of the nuances and secure supplies of COVID-19 vaccines, given that a large part of...